CONCOMITANT DISEASE PROGRESSION

This adverse event was reported 1956 times

These drugs are most commonly taken by patients reporting CONCOMITANT DISEASE PROGRESSION:

# Drug Count
0 FUROSEMIDE 181
1 CYCLOSPORINE 115
2 ASPIRIN 105
3 ASPIRIN 325 MG 102
4 ASPIRIN 81 MG 102
5 ALISKIREN 91
6 ALISKIREN HEMIFUMARATE 91
7 COAGULATION FACTOR VIIA (RECOMBINANT) 88
8 EVEROLIMUS 86
9 SPIRONOLACTONE 79
See all common drugs associated with CONCOMITANT DISEASE PROGRESSION

CONCOMITANT DISEASE PROGRESSION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Prostacycline [EPC] 4 0.0043
1 Enzyme Stabilizer [EPC] 3 0.0026
2 Provitamin D2 Compound [EPC] 68 0.0023
3 Vasopressin V2 Receptor Antagonist [EPC] 24 0.0016
4 Iron Chelator [EPC] 45 0.0015
5 Vitamin D2 Analog [EPC] 9 0.0013
6 Echinocandin Antifungal [EPC] 9 0.0011
7 Prostacyclin Receptor Agonist [EPC] 28 0.0011
8 Glucosylceramide Synthase Inhibitor [EPC] 3 0.0011
9 Cholinesterase Inhibitor [EPC] 17 0.0009
See all drug classes enriched for association with CONCOMITANT DISEASE PROGRESSION